Lucid Diligence Brief - BioPharma

IDEAYA and Roche Collaboration | Lucid Diligence Brief

IDEAYA and Roche Test IDE892 plus RG6505 in MTAP-Deleted RAS-Mutant PDAC…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal oncology $1.5B deal

Lucid Diligence Brief: Genhouse Bio and Gilead in GH31 synthetic-lethal…


Privacy Preference Center